Detalles de la búsqueda
1.
SARS-CoV-2 Clinical Outcomes in Patients with Cancer in a Large Integrated Health Care System in Northern California.
Oncologist
; 26(3): e500-e504, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33210439
2.
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma.
Invest New Drugs
; 32(1): 178-87, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24242861
3.
Choriocarcinoma Syndrome: A Rare Complication's Impact on Metastatic Germ Cell Tumor Outcomes.
Cureus
; 16(4): e58388, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38756265
4.
Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide.
Eur Urol Oncol
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38523017
5.
Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib.
Eur Urol
; 83(3): 200-209, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36243543
6.
Quality of life for men with metastatic castrate-resistant prostate cancer participating in an aerobic and resistance exercise pilot intervention.
Urol Oncol
; 41(3): 146.e1-146.e11, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36528473
7.
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).
J Clin Oncol
; 40(28): 3301-3309, 2022 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35446628
8.
A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma.
Cancer
; 117(18): 4194-200, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21387258
9.
Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clinical Trials Consortium.
Cancer
; 117(11): 2419-25, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24048789
10.
Implementation of a Multidisciplinary Expert Testicular Cancer Tumor Board Across a Large Integrated Healthcare Delivery System Via Early Case Ascertainment.
JCO Clin Cancer Inform
; 5: 187-193, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33571000
11.
Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216).
Clin Cancer Res
; 27(7): 1967-1973, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33500355
12.
Feasibility, safety, and acceptability of a remotely monitored exercise pilot CHAMP: A Clinical trial of High-intensity Aerobic and resistance exercise for Metastatic castrate-resistant Prostate cancer.
Cancer Med
; 10(22): 8058-8070, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636156
13.
Immunotherapeutics in development for prostate cancer.
Oncologist
; 14(4): 391-8, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19342474
14.
A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer.
BJU Int
; 101(4): 436-9, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18234062
15.
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study.
Urol Oncol
; 35(4): 149.e7-149.e13, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28161323
16.
Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab.
Cancer Immunol Res
; 3(9): 1008-16, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25968455
17.
Effects of cabozantinib on pain and narcotic use in patients with castration-resistant prostate cancer: results from a phase 2 nonrandomized expansion cohort.
Eur Urol
; 67(2): 310-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24631409
18.
Phase II results of Dovitinib (TKI258) in patients with metastatic renal cell cancer.
Clin Cancer Res
; 20(11): 3012-22, 2014 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24691021
19.
Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens.
Clin Cancer Res
; 20(24): 6269-76, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25336698
20.
Cabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.
J Clin Oncol
; 32(30): 3391-9, 2014 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-25225437